Gregory T Went - Net Worth and Insider Trading

Gregory T Went Net Worth

The estimated net worth of Gregory T Went is at least $3 Million dollars as of 2024-05-14. Gregory T Went is the CEO of Adamas Pharmaceuticals Inc and owns about 375,533 shares of Adamas Pharmaceuticals Inc (ADMS) stock worth over $3 Million. Details can be seen in Gregory T Went's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gregory T Went has not made any transactions after 2019-03-20 and currently still holds the listed stock(s).

Transaction Summary of Gregory T Went

To

Gregory T Went Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Gregory T Went owns 1 companies in total, including Adamas Pharmaceuticals Inc (ADMS) .

Click here to see the complete history of Gregory T Went’s form 4 insider trades.

Insider Ownership Summary of Gregory T Went

Ticker Comapny Transaction Date Type of Owner
ADMS Adamas Pharmaceuticals Inc 2019-04-08 director & Chief Executive Officer

Gregory T Went Latest Holdings Summary

Gregory T Went currently owns a total of 1 stock. Gregory T Went owns 375,533 shares of Adamas Pharmaceuticals Inc (ADMS) as of March 20, 2019, with a value of $3 Million.

Latest Holdings of Gregory T Went

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ADMS Adamas Pharmaceuticals Inc 2019-03-20 375,533 8.22 3,086,881

Holding Weightings of Gregory T Went


Gregory T Went Form 4 Trading Tracker

According to the SEC Form 4 filings, Gregory T Went has made a total of 0 transactions in Adamas Pharmaceuticals Inc (ADMS) over the past 5 years. The most-recent trade in Adamas Pharmaceuticals Inc is the sale of 6,319 shares on March 20, 2019, which brought Gregory T Went around $50,489.

Insider Trading History of Gregory T Went

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Gregory T Went Trading Performance

GuruFocus tracks the stock performance after each of Gregory T Went's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gregory T Went is -31.39%. GuruFocus also compares Gregory T Went's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gregory T Went within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Gregory T Went's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Gregory T Went

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -23.58
Relative Return to S&P 500(%) -17.15

Gregory T Went Ownership Network

Ownership Network List of Gregory T Went

No Data

Ownership Network Relation of Gregory T Went


Gregory T Went Owned Company Details

What does Adamas Pharmaceuticals Inc do?

Who are the key executives at Adamas Pharmaceuticals Inc?

Gregory T Went is the director & Chief Executive Officer of Adamas Pharmaceuticals Inc. Other key executives at Adamas Pharmaceuticals Inc include Chief Commercial Officer Vijay Shreedhar , Chief Financial Officer Christopher B Prentiss , and director & 10 percent owner William W. Ericson .

Adamas Pharmaceuticals Inc (ADMS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Adamas Pharmaceuticals Inc (ADMS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adamas Pharmaceuticals Inc (ADMS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Adamas Pharmaceuticals Inc (ADMS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Adamas Pharmaceuticals Inc Insider Transactions

No Available Data

Gregory T Went Mailing Address

Above is the net worth, insider trading, and ownership report for Gregory T Went. You might contact Gregory T Went via mailing address: C/o Adamas Pharmaceuticals, Inc. 2200 Powell St, Ste 220 Emeryville Ca 94608.

Discussions on Gregory T Went

No discussions yet.